# BALANCE-DM2 Study of Bofanglutide in Adults With Type 2 Diabetes

> **NCT07628985** · PHASE3 · NOT_YET_RECRUITING · sponsor: **Carnot Laboratories** · enrollment: 374 (estimated)

## Conditions studied

- Type 2 Diabetes Mellitus (T2DM)

## Interventions

- **BIOLOGICAL:** Bofanglutide
- **BIOLOGICAL:** Semaglutide

## Key facts

- **NCT ID:** NCT07628985
- **Lead sponsor:** Carnot Laboratories
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-09
- **Primary completion:** 2027-10
- **Final completion:** 2027-10
- **Target enrollment:** 374 (ESTIMATED)
- **Last updated:** 2026-06-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07628985

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07628985, "BALANCE-DM2 Study of Bofanglutide in Adults With Type 2 Diabetes". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07628985. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*